TH32710A - Lll form crystals of calcium salt (2 - Google Patents
Lll form crystals of calcium salt (2Info
- Publication number
- TH32710A TH32710A TH9601002375A TH9601002375A TH32710A TH 32710 A TH32710 A TH 32710A TH 9601002375 A TH9601002375 A TH 9601002375A TH 9601002375 A TH9601002375 A TH 9601002375A TH 32710 A TH32710 A TH 32710A
- Authority
- TH
- Thailand
- Prior art keywords
- calcium salt
- form crystals
- substances
- phenyl
- lll
- Prior art date
Links
- 159000000007 calcium salts Chemical class 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
- 239000000126 substance Substances 0.000 claims abstract 3
- 238000005481 NMR spectroscopy Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- -1 methyl Ethyl Chemical group 0.000 abstract 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 abstract 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000000371 solid-state nuclear magnetic resonance spectroscopy Methods 0.000 abstract 1
Abstract
บรรยายรูปแบบผลึกใหม่ของ (R-(R*,R*))- 2-(4-ฟลูออโรเฟนิล)-เบตา,เดลตา-ได- ไฮดรอกซิ-5-(เมธิลเอธิล)-3-เฟนิล- 4-((เฟนิลอะมิโน)คาร์บอนิล)-1-H-พิร์โรล-1-เฮป- ทานออิค แอซิด เกลือเฮมิ แคลเซียมที่เรียกรูปแบบ III บ่งบอกเอกลักษณ์โดย X-เรย์เพา- เดอร์ ดิฟแฟรคชันและ/หรือ โซลิค สเทท NMR รวมทั้งวิธีการเตรียมสารผสมเภสัชกรรมของ สารเหล่านี้ ซึ่งเป็นประโยชน์เป็นสารสำหรับการบำบัดไฮเปอร์ลิปิดีเมีย และไฮเปอร์คอเลส- เตอโรลีเมีย สิทธิบัตรยา Describe the new crystalline form of (R- (R *, R *)) - 2- (4- fluorophenyl) - beta, delta-di-hydroxy-5- (methyl Ethyl) -3-phenyl - 4 - ((phenyl amino) carbonyl) -1-H-piroll-1-hep-tanol-acid, hemicalcium salt The so-called form III is uniquely identified by the X-ray powdersdiffration and / or solid state NMR, as well as the pharmaceutical mixtures of these substances. Substances for the treatment of hyperlipidemia And hypercholesterolemia - Taurolemia drug patent
Claims (2)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH32710A true TH32710A (en) | 1999-03-20 |
| TH13382B TH13382B (en) | 2002-08-29 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA966045B (en) | Form III crystalline [R-(R*,R*)]-2-(4-fluorophenyl)-B,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1). | |
| EA199800130A1 (en) | CRYSTAL ACID CALCIUM SALT [R- (R, * R *)] - 2- (4-Fluoro-phenyl) -BETA, DELTA-DIHYDROXI-5- (1-METHYLETHYL) -3-PHENYL-4 - [(PHENYLAMINE) CARBON -1H-PIRROL-1-HEPTANA ACID (ATORVASTATIN) | |
| NO920401L (en) | THERMOFORMAL RELATIONSHIPS, PROCEDURES FOR THEIR PREPARATION AND THEIR USE OF AA TERMOFORMED ARTICLES | |
| MXPA03010266A (en) | Crystalline forms of 'r-(r*, r*)!-2 -(4-fluorophenyl)- beta, delta-dihydroxy -5-(1-methylethyl) -3-phenyl -4-'phenylamino)carbonyl !-1h-pyrrole -1-heptanoic acid calcium salt (2:1) (atorvastatin). | |
| DK0839132T5 (en) | Process for the preparation of amorphous [R- (R *, R *)] - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) carbonyl ] -1H-pyrrole-1-heptanoic acid calcium salt (2: 1) | |
| BG103250A (en) | MODIFIED AMINO ACIDS AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS | |
| DK0513543T3 (en) | Amidinophenylalanine derivatives, processes for their preparation, their use and anticoagulants containing them | |
| EA200300104A1 (en) | NEW γ CRYSTAL FORM OF TREAT-BUTYLAMINE SALT PERINDOPRIL, METHOD FOR ITS PREPARATION AND CONTAINING ITS PHARMACEUTICAL COMPOSITIONS | |
| EA200300103A1 (en) | NEW β CRYSTAL FORM OF TREAT-BUTYLAMINE SALT PERINDOPRIL, METHOD FOR ITS PREPARATION AND CONTAINING ITS PHARMACEUTICAL COMPOSITIONS | |
| DK0652002T3 (en) | Use of 2-phenyl-3-aroylebenzothiophenes in the manufacture of a drug for inhibiting cartilage degradation | |
| RU98113525A (en) | The use of 2-phenyl-3-aroylbenzothiophenes for the inhibition of thrombotic disorder, to increase the activation of protein C | |
| TH32710A (en) | Lll form crystals of calcium salt (2 | |
| DK0484966T3 (en) | 7-Acrylic-3- (substituted carbamoyloxy) cephem compounds, use thereof and process thereof | |
| TH13382B (en) | Lll form crystals of calcium salt (2 | |
| FI935799A0 (en) | Aryl substituted heterocyclic moieties | |
| ATE78462T1 (en) | GUANIDINIUM COMPOUNDS AND FUNGICIDES CONTAINING THEM. | |
| ATE195314T1 (en) | ALKYL-SUBSTITUTED HETEROCYCLIC COMPOUNDS | |
| DE60009695D1 (en) | CRYSTALLINE CABAPEN DERIVATIVES AND PHARMACEUTICAL PREPARATIONS FOR INJECTION | |
| DE69616358D1 (en) | CRYSTALLINE FORM III OF THE HEMI CALCIUM SALTS OF [R- (R *, R *)] - 2- (4-FLUORPHENYL) -BETA-DELTA-DIHYDROXY-5- (1-METHYLETHYL) -3-PHENYL-4 - [( PHENYLAMINO) CARBONYL] -1H-PYRROL-1-HEPTANIC ACID (ATORVASTATIN) | |
| RU93043526A (en) | INDENOINDAL COMPOUNDS, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION, ANTI-OXIDATIVE COMPOSITION, METHOD OF STABILIZATION | |
| MXPA00012407A (en) | Novel substituted pyrrole compound. | |
| CA2522899A1 (en) | Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) | |
| TH61086A (en) | Crystalline form of calcium salts (2 | |
| ATE154243T1 (en) | BLOOD VESSEL HYPERTROPHY INHIBITOR | |
| RU94019328A (en) | α- HETEROARILOXYMETYLKETONES, PHARMACEUTICAL COMPOSITION, INHIBITING INTERLEUKIN-1 - β-PROTEASIS |